Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1644642Generated: October 31, 2026

3-Isoxazolamine, 5-(1,1-dimethylethyl)- → HCID 25204104, compound

https://huagongshe.com/reaction/1644642

Reaction equation

Participants

RoleNameHCIDCharge
Reactant3-Isoxazolamine, 5-(1,1-dimethylethyl)-HCID 171473—
Reactant1,1'-(9,9-Dimethyl-9H-xanthene-4,5-diyl)bis(1,1-diphenylphosphine)HCID 636044—
Reactant4-Iodo-N-(thiazol-2-yl)benzenesulfonamideHCID 1019318—
ReactantSodium t-butoxideHCID 23676156—
CatalystBis(dibenzylideneacetone)palladiumHCID 9811564—
Solvent1,4-DioxaneHCID 31275—
ProductHCID 25204104HCID 252041041,478.4%

Reaction Conditions

Temperature150 °C

Reaction Steps

To a mixture of 4-iodo-N-thiazol-2-yl-benzenesulfonamide (50 mg, 0.1 mmol, 1.0 equiv), tris(dibenzylideneacetone)dipalladium(0) (5 mg, 0.005 mmol, 0.04 equiv), 9,9-dimethyl-4,5-bis(diphenylphosphino)xanthene (10 mg, 0.0016 mmol, 0.12 equiv) and 3-amino-5-tert-butylisoxazole (23 mg, 0.16 mmol, 1.2 equiv) in 1.8 mL of anhydrous 1,4-dioxane was added sodium tert-butoxide (39 mg, 0.41 mmol, 3.0 equiv). The vial was capped, and the reaction mixture was heated 30 min at 150° C. in the microwave. The crude reaction mixture was filtered through celite then concentrated in vacuo. The residue was taken up in chloroform-methanol, concentrated onto celite, and purified via automated flash chromatography (12 g SiO2, gradient from hexanes to ethyl acetate). The appropriate fractions were collected, concentrated in vacuo, then purified further via reverse phase HPLC. The solvent was removed by lyophilization to afford the product as a white solid (9 mg, 20%).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08124610B2
Source datasetuspto-grants-2012_02
ORD IDord-12fcc208f79847769d4dd254cbc1958c
Source noteuspto-grants-2012_02